Essex Investment Management’s Evolent Health EVH Stock Holding History

Essex Investment Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-65,884	Closed	-$1.79M	–	345
2023 Q3	$1.79M	Sell	65,884 -462	-0.7%	-$12.8K	0.29%	116
2023 Q2	$2.01M	Buy	66,346 +9,645	+17%	+$312K	0.28%	127
2023 Q1	$1.84M	Buy	56,701 +10,829	+24%	+$342K	0.27%	123
2022 Q4	$1.29M	Sell	45,872 -461	-1%	-$13.2K	0.2%	159
2022 Q3	$1.67M	Buy	46,333 +3,369	+8%	+$119K	0.27%	120
2022 Q2	$1.32M	Buy	+42,964	New	+$1.25M	0.21%	141

Other funds holding EVH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Essex Investment Management's EVH Position: Q4 2023 in Review

Essex Investment Management sold out of Evolent Health (EVH) in Q4 2023, closing a stake of 65,884 shares — an estimated $1.79M sold.

Essex Investment Management first reported a position in EVH in Q2 2022 and held it in 6 quarters. The position peaked at $2.01M in Q2 2023. 234 funds tracked by Wall St. Rank hold EVH as of Q4 2023.

Essex Investment Management reported no remaining Evolent Health position as of Q4 2023 after selling out during the quarter.
Essex Investment Management sold 65,884 Evolent Health shares in Q4 2023, an estimated $1.79M.
Essex Investment Management first reported a position in Evolent Health in Q2 2022 and held it in 6 quarters.
Essex Investment Management's Evolent Health position peaked at $2.01M in Q2 2023.
234 funds tracked by Wall St. Rank held Evolent Health as of Q4 2023.

Based on Essex Investment Management's 13F filing for Q4 2023, filed 8 Feb 2024.